News

According to a new study, higher omega-3 levels significantly reduce the risk of heart failure and heart failure fatalities.

A potassium binder helped patients with heart failure who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk.

The new Saint Luke’s Muriel I. Kauffman Institute for Women’s Cardiovascular Research is the first of its kind dedicated to studying unique aspects of heart conditions in women.

A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.

Dr. Tracy Stevens and Dr. Anna Grodzinsky joined the America's Healthcare Advocate podcast to talk about heart conditions in women.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

FOX4 talked to Dr. Tracy Stevens about how women have been underrepresented in cardiovascular research and how the new institute plans to make a difference.

On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.